
Rohto Pharmaceutical Company (PK) (RPHCF)
USOTC
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Return on Assets (%) | 5.544 | 4.859 | 4.878 | 7.404 | 7.592 | 8.4 | 9.029 | 9.434 |
Return on Equity (%) | 8.716 | 7.525 | 7.519 | 11.322 | 11.288 | 12.347 | 13.225 | 13.389 |
Return on Invested Capital (%) | 13.363 | 13.082 | 8.794 | 15.944 | 15.486 | 16.8 | 15.959 | 16.002 |
Operating Margin (%) | 9.629 | 9.877 | 8.959 | 11.605 | 12.77 | 14.126 | 14.471 | 15.402 |
Net Profit Margin (%) | 6.475 | 5.409 | 5.338 | 8.183 | 9.236 | 10.528 | 11.052 | 11.422 |
Book Value Per Share | 981.66 | 1054.241 | 1090.126 | 1140.784 | 1262.412 | 1478.046 | 870.178 | 1006.952 |
Earnings Per Share | 84.885 | 78.763 | 83.049 | 130.495 | 141.783 | 177.984 | 111.683 | 130.986 |
Cash Per Share | 202.856 | 258.886 | 320.841 | 383.668 | 448.509 | 616.408 | 338.52 | 377.724 |
Working Capital Per Share | 402.981 | 449.091 | 471.582 | 575.761 | 648.663 | 786 | 466.106 | 540.575 |
Operating Profit Per Share | 813.45 | 895.91 | 972.337 | 1013.083 | 945.948 | 1034.017 | 604.98 | 692.787 |
EBIT Per Share | 125.085 | 142.62 | 138.147 | 184.014 | 194.819 | 236.711 | 145.187 | 175.791 |
EBITDA Per Share | 125.085 | 142.62 | 138.147 | 184.014 | 194.819 | 236.711 | 145.187 | 175.791 |
Free Cash Flow Per Share | 88.692 | 96.094 | 111.535 | 151.327 | 198.935 | 243.706 | 141.851 | 158.016 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 117,94M | 117,94M | 117,99M | 118,09M | 118,09M | 118,09M | 236,18M | 236,18M |
Capitalisation boursière | 4,58B |
Ratio cours/bénéfice | 0,15 |
Ratio prix/ventes | 0,02 |
Ratio prix/liquidités | 0,05 |
Ratio prix/valeur comptable | 0,02 |
Rendement de dividende | 13 439,52% |
Actions en circulation | 228,14M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | -1,95% |
Plus haut sur 52 semaines | 21,542 |
Plus bas sur 52 semaines | 18,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales